Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.32 +0.27 (+0.31%)
At close: Oct 1, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Cash & Equivalents (2017 - 2025)

Updated

Dianthus Therapeutics' Cash & Equivalents came in at $51.09 million for Q4 2025, up 124.1% from $22.79 million a year earlier but down 8.7% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Cash & Equivalents (2017 - 2025) Analysis & Trends

Going back to Q2 2017, Dianthus Therapeutics' Cash & Equivalents data covers 34 quarters.

  • Cash & Equivalents carries a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $22.79 million in FY2024 (-82.8%), $132.33 million in FY2023 (+761.2%), $15.37 million in FY2022 (-88.3%) and $131.65 million in FY2021 (+126.4%).
  • The five-year range for quarterly Cash & Equivalents is $10.12 million (Q1 2025) to $329.72 million (Q1 2024).
  • Year-over-year, Cash & Equivalents increased in three of the last seven quarters, with growth averaging 73.8%.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2023 (growth of 761.2%), and the weakest in Q1 2025 (a decline of 96.9%).
  • Business Quant data shows DNTH's Cash & Equivalents at $55.98 million (Q3 2025), $13.24 million (Q2 2025) and $10.12 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 20.42 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.57 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.18 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 976.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 6.14 Bn
10 Dianthus Therapeutics 3.77 Bn 3.72 Bn - 51.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 51.09 Mn
Sep 30, 2025 55.98 Mn
Jun 30, 2025 13.24 Mn
Mar 31, 2025 10.12 Mn
Dec 31, 2024 22.79 Mn
Sep 30, 2024 33.67 Mn
Jun 30, 2024 314.17 Mn
Mar 31, 2024 329.72 Mn
Dec 31, 2023 132.33 Mn
Sep 30, 2023 157.28 Mn
Jun 30, 2023 40.28 Mn
Mar 31, 2023 23.21 Mn
Dec 31, 2022 15.37 Mn
Sep 30, 2022 36.88 Mn
Jun 30, 2022 54.83 Mn
Mar 31, 2022 71.77 Mn
Dec 31, 2021 131.65 Mn
Sep 30, 2021 157.54 Mn
Jun 30, 2021 155.03 Mn
Mar 31, 2021 49.29 Mn
API Access

Dianthus Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=DNTH&period=max&api_key=YOUR_API_KEY